{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:06:25Z","timestamp":1758085585524,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.yexmp.2019.104297","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T19:17:28Z","timestamp":1567192648000},"page":"104297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical features and molecular genetic analysis of thanatophoric dysplasia type I in a neonate with a de novo c.2419\u202fT\u202f&gt;\u202fC (p. Ter807Arg) (X807R) mutation in FGFR3"],"prefix":"10.1016","volume":"111","author":[{"given":"Gaoli","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liling","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2019.104297_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexmp.2019.104297_bb0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1096-8628(19970627)70:4<427::AID-AJMG18>3.0.CO;2-J","article-title":"Long-term survival in typical thanatophoric dysplasia type 1","volume":"70","author":"Baker","year":"1997","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0015","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/j.1742-4658.2007.05835.x","article-title":"The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor","volume":"274","author":"Bonaventure","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.yexmp.2019.104297_bb0020","first-page":"274","article-title":"Thanatophoric dysplasia type I with syndactyly","volume":"78","author":"Brodie","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tjog.2016.12.013","article-title":"Perinatal imaging findings and molecular genetic analysis of thanatophoric dysplasia type 1 in a fetus with a c.2419T>G (p.Ter807Gly) (X807G) mutation in FGFR3","volume":"56","author":"Chen","year":"2017","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"10.1016\/j.yexmp.2019.104297_bb0030","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-0528.2002.01022.x","article-title":"Charts of fetal size: limb bones","volume":"109","author":"Chitty","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.yexmp.2019.104297_bb0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/pd.4066","article-title":"Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA","volume":"33","author":"Chitty","year":"2013","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.yexmp.2019.104297_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bpj.2014.11.3460","article-title":"Effect of thanatophoric dysplasia type I mutations on FGFR3 dimerization","volume":"108","author":"Del-Piccolo","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.yexmp.2019.104297_bb0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.21636","article-title":"Sixteen years and counting:the current understanding of fibroblast growth factor receptor 3(FGFR3) signaling in skeletal dysplasias","volume":"33","author":"Foldynova-Trantirkova","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.yexmp.2019.104297_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000486697","article-title":"Novel and recurrent mutations in the FGFR3 gene and double heterozygosity cases in a cohort of Brazilian patients with skeletal dysplasia","volume":"9","author":"Gomes","year":"2018","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.yexmp.2019.104297_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yexmp.2017.02.019","article-title":"Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation","volume":"102","author":"Jung","year":"2017","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2019.104297_bb0060","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non- synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Kumar","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yexmp.2019.104297_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/uog.5192","article-title":"Fetal biometry in ethnic Chinese: biparietal diameter, head circumference, abdominal circumference and femur length","volume":"31","author":"Leung","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.yexmp.2019.104297_bb0070","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/ajmg.a.37609","article-title":"Identification of a novel insertion mutation in FGFR3 that causes thanatophoric dysplasia type 1","volume":"170","author":"Lindy","year":"2016","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.yexmp.2019.104297_bb0075","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/ajmg.a.32880","article-title":"Thanatophoric dysplasia caused by double missense FGFR3 mutations","volume":"149A","author":"Pannier","year":"2009","journal-title":"Am. J. Med. Genet. Part A."},{"key":"10.1016\/j.yexmp.2019.104297_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/ng0595-11","article-title":"Stop codon FGFR3 mutations in thanatophoric dwarfism type 1","volume":"10","author":"Rousseau","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/5.4.509","article-title":"Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)","volume":"5","author":"Rousseau","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0090","first-page":"513","article-title":"A thanatophoric dysplasia type I case with a p. R248C mutation and survival beyond the neonatal period","volume":"27","author":"Sahin","year":"2016","journal-title":"Genet. Couns."},{"key":"10.1016\/j.yexmp.2019.104297_bb0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nmeth0810-575","article-title":"Mutation taster evaluates disease-causing potential of sequence alterations","volume":"7","author":"Schwarz","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexmp.2019.104297_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng0395-321","article-title":"Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3","volume":"9","author":"Tavormina","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0105","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1093\/hmg\/4.11.2175","article-title":"Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I","volume":"4","author":"Tavormina","year":"1995","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/(SICI)1096-8628(19980707)78:3<274::AID-AJMG14>3.0.CO;2-C","article-title":"Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia","volume":"78","author":"Wilcox","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.yexmp.2019.104297_bb0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mgg3.96","article-title":"FGFR3 mutation frequency in 324 cases from the international skeletal dysplasia registry","volume":"2","author":"Xue","year":"2014","journal-title":"Mol. Genet. Genomic. Med."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019303521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019303521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T02:48:45Z","timestamp":1757990925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019303521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"alternative-id":["S0014480019303521"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104297","relation":{},"ISSN":["0014-4800"],"issn-type":[{"type":"print","value":"0014-4800"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and molecular genetic analysis of thanatophoric dysplasia type I in a neonate with a de novo c.2419\u202fT\u202f>\u202fC (p. Ter807Arg) (X807R) mutation in FGFR3","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2019.104297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104297"}}